Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
International Journal of Radiation Oncology, Biology, Physics|May 1, 2016
Cost Analysis of Complex Radiation Therapy for Patients With Head and Neck CancerLionel Perrier, Magali Morelle, Pascal Pommier, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trialJean Bourhis, Michel Lapeyre, Jacques Tortochaux, et al.International Journal of Radiation Oncology, Biology, Physics|December 28, 2017
Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer PatientsYungan Tao, Anne Auperin, Christian Sire, et al.Oral Oncology|July 10, 2017
Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trialsYungan Tao, Anne Aupérin, Pierre Graff, et al.International Journal of Radiation Oncology, Biology, Physics|September 3, 2017
Clinical Outcomes of Several IMRT Techniques for Patients With Head and Neck Cancer: A Propensity Score-Weighted AnalysisJean-Emmanuel Bibault, Sophie Dussart, Pascal Pommier, et al.The Lancet. Oncology|January 21, 2014
Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised studyJean-François Bosset, Gilles Calais, Laurent Mineur, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2013
Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II studyJean Louis Lefebvre, Yoann Pointreau, Frederic Rolland, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2018
Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized TrialYungan Tao, Anne Auperin, Christian Sire, et al.The Lancet. Oncology|January 21, 2012
Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trialJean Bourhis, Christian Sire, Pierre Graff, et al.Bulletin Du Cancer|November 21, 2002
[2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer]Jeanne-Marie Bréchot, Thierry Molina, Serge Theobald, et al.Pageof 4